Attached files
| file | filename |
|---|---|
| 10-K - CASI Pharmaceuticals, Inc. | v178789_10k.htm |
| EX-32.1 - CASI Pharmaceuticals, Inc. | v178789_ex32-1.htm |
| EX-31.1 - CASI Pharmaceuticals, Inc. | v178789_ex31-1.htm |
| EX-31.2 - CASI Pharmaceuticals, Inc. | v178789_ex31-2.htm |
| EX-23.1 - CASI Pharmaceuticals, Inc. | v178789_ex23-1.htm |
Exhibit
32.2
CERTIFICATION
BY PRINCIPAL ACCOUNTING OFFICER
PURSUANT
TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002
In
connection with the Annual Report of EntreMed, Inc. (the “Company”) on Form 10-K
for the period ended December 31, 2009 as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I, Kathy Wehmeir-Davis, as
Principal Accounting Officer of the Company, hereby certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of` the Sarbanes-Oxley
Act of 2002, to the best of my knowledge, that:
|
|
(1)
|
The
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company
|
This
certificate is being made for the exclusive purpose of compliance by the
Principal Accounting Officer of the Company with the requirements of Section 906
of the Sarbanes-Oxley Act of 2002, and may not be used by any person or for any
reason other than as specifically required by law.
|
/s/ Kathy R.
Wehmeir-Davis
|
|
|
March
29, 2010
|
Kathy
R. Wehmeir-Davis
Principal
Accounting Officer
|